A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.

Phase 2

Coria Laboratories, Ltd.

Tretinoin